Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.

BMC medical genetics - 6 Jul 2017

Landoulsi Zied, Benromdhan Sawssan, Ben Djebara Mouna, Damak Mariem, Dallali Hamza, Kefi Rym, Abdelhak Sonia, Gargouri-Berrechid Amina, Mhiri Chokri, Gouider Riadh

Abstract excerpt

BACKGROUND: In North African populations, G2019S mutation in LRRK2 gene, encoding for the leucine-rich repeat kinase 2, is the most prevalent mutation linked to familial and sporadic Parkinson's disease (PD). Early detection of G2019S by fast genetic testing is very important to guide PD's diagnosis and support patients and their family caregivers for better management of their life according to disease's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Mutation Rate

Share to Parkinson Disease

Share to Polymerase Chain Reaction

Share to Tunisia

Source

Open in PubMed Open full text

Identifiers

PMID: 28683740
DOI: 10.1186/s12881-017-0432-5
PMCID: PMC5501550

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.PMID 28683740Read ↗

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.Semantic proximity Read ↗

Leucine rich repeat kinase 2 (LRRK2) gly2019ser mutation is absent in a second cohort of nigerian africans with parkinson diseaseSemantic proximity Read ↗

Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson diseaseSemantic proximity Read ↗

G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.Semantic proximity Read ↗

LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s DiseaseSemantic proximity Read ↗

Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.Semantic proximity Read ↗

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.Semantic proximity Read ↗

G2019S LRRK2 mutation in French and North African families with Parkinson's disease.Semantic proximity Read ↗

LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic.Semantic proximity Read ↗

LRRK2 G2019S in the North African population: a review.Semantic proximity Read ↗

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.Semantic proximity Read ↗

The p.Gly2019Ser is the commonest pathogenic mutation in the LRRK2 gene among Egyptians with familial and sporadic Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.